Earnings Feed
Start Free
Home/Filings/4/0001142576-13-000015
4//SEC Filing

OPTIMER PHARMACEUTICALS INC 4

Accession 0001142576-13-000015

CIK 0001142576operating
View on SEC.govCompany Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 1:40 PM ET

Size

35.1 KB

Accession

0001142576-13-000015

Insider Transaction Report

Form 4
Period: 2013-09-04
OPTIMER PHARMACEUTICALS INCOPTR
Chang Michael N
DirectorCEO and President
Transactions
  • Exercise/Conversion

    Common stock

    2013-09-04$6.90/sh+70,000$483,000→ 1,018,956 total
  • Exercise/Conversion

    Common stock

    2013-09-04$9.70/sh+30,000$291,000→ 372,761 total(indirect: By Spouse)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−4,615→ 0 total(indirect: By Spouse)
    Exercise: $2.17Exp: 2016-09-13→ Common stock (4,615 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−9,000→ 11,000 total(indirect: By Spouse)
    Exercise: $11.41Exp: 2021-01-26→ Common stock (9,000 underlying)
  • Exercise/Conversion

    Common stock

    2013-09-04$2.17/sh+4,615$10,015→ 342,761 total(indirect: By Spouse)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−70,000→ 0 total
    Exercise: $6.90Exp: 2018-01-04→ Common stock (70,000 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−30,000→ 0 total(indirect: By Spouse)
    Exercise: $9.70Exp: 2017-03-29→ Common stock (30,000 underlying)
  • Exercise/Conversion

    Common stock

    2013-09-04$9.70/sh+100,000$970,000→ 948,956 total
  • Exercise/Conversion

    Common stock

    2013-09-04$9.56/sh+8,000$76,480→ 1,026,956 total
  • Exercise/Conversion

    Common stock

    2013-09-04$6.90/sh+30,000$207,000→ 402,761 total(indirect: By Spouse)
  • Exercise/Conversion

    Common stock

    2013-09-04$10.75/sh+30,000$322,500→ 432,761 total(indirect: By Spouse)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−8,000→ 2,000 total
    Exercise: $9.56Exp: 2020-12-01→ Common stock (8,000 underlying)
  • Exercise/Conversion

    Common stock

    2013-09-04$11.41/sh+9,000$102,690→ 441,761 total(indirect: By Spouse)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−100,000→ 0 total
    Exercise: $9.70Exp: 2017-03-29→ Common stock (100,000 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−30,000→ 0 total(indirect: By Spouse)
    Exercise: $6.90Exp: 2018-01-04→ Common stock (30,000 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2013-09-04−30,000→ 0 total(indirect: By Spouse)
    Exercise: $10.75Exp: 2019-01-08→ Common stock (30,000 underlying)
Footnotes (7)
  • [F1]25% of the options vested on March 29, 2008 and 1/48 of the options vested each month thereafter.
  • [F2]25% of the options vested on January 4, 2009 and 1/48 of the options vested each month thereafter.
  • [F3]1/12th of the shares subject to the stock option vested and became exercisable each month, commencing February 1, 2011.
  • [F4]25% of the options vested on October 1, 2007 and 1/48 of the options vested each month thereafter.
  • [F5]On January 4, 2008, Mrs. Che was granted an option to purchase 30,000 shares of common stock. 1/4 of the shares subject to the option vested on January 4, 2009. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 equal monthly installments subject to Mrs. Che continuing to be service provider on each such date. At the time of Mrs. Che's separation in January 2012, the option: (i) had vested as to 29,375 shares; and (ii) was accelerated as to 625 shares in accordance with her separation agreement.
  • [F6]On January 8, 2009, Mrs. Che was granted an option to purchase 30,000 shares of common stock. 1/4 of the shares subject to the option vested on January 8, 2010. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 equal monthly installments subject to Mrs. Che continuing to be service provider on each such date. At the time of Mrs. Che's separation in January 2012, the option: (i) had vested as to 21,875 shares; and (ii) was accelerated as to 8,125 shares in accordance with her separation agreement.
  • [F7]On January 26, 2011, Mrs. Che was granted an option to purchase 20,000 shares of common stock. 1/4 of the shares subject to the option vested on January 26, 2012. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 equal monthly installments subject to Mrs. Che continuing to be service provider on each such date. At the time of Mrs. Che's separation in January 2012, the option: (i) had no shares vested; and (ii) was accelerated as to 20,000 shares in accordance with her separation agreement.

Documents

1 file

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001142576

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 1:40 PM ET
Size
35.1 KB
View on SEC.gov